Patent US5840300A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5840300A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods and compositions comprising single chain recombinant antibodies

Assignee: University of Pennsylvania
•
Filing: 1995-09-11
•
Granted: 1998-11-24
•
Expires: 2015-09-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods and compositions for the generation of single chain antibody fragments.

Inventors

  • 👤 William V. Williams
  • 👤 David B. Weiner

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 09:54
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/08; C07K16/10; C07K16/112; C07K16/114; C07K16/1145; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 61 words
A recombinant single chain antibody molecule selected from the group consisting of SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19 and SEQ ID NO:20.
Claim 2
Dependent Claim 61 words
A recombinant single chain antibody molecule selected from the group consisting of SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19 and SEQ ID NO:20.
Claim 3
Dependent Claim 13 words
An isolated DNA encoding the recombinant single chain antibody molecule of claim 1.
Claim 4
Independent Claim 81 words
A method of treating a human infected with Human Immunodeficiency Virus type 1 (HIV-1) comprising administering to said human a recombinant single chain antibody molecule selected from the group consisting of SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO: 13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19 and SEQ ID NO:20.
Claim 5
Independent Claim 81 words
A method of treating a human infected with Human Immunodeficiency Virus type 1 (HIV-1) comprising administering to said human a recombinant single chain antibody molecule selected from the group consisting of SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO: 13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19 and SEQ ID NO:20.
Claim 6
Dependent Claim 3 words
The vector, pMARS8.
Claim 7
Dependent Claim 3 words
The vector, pMARS8.
Claim 8
Independent Claim 90 words
A method of treating a human infected with Human Immunodeficiency Virus comprising administering to said human a pharmaceutical composition that consists essentially of a virus neutralizing recombinant single chain antibody molecule selected from the group consisting of SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19 and SEQ ID NO:20 providing passive inmunity.
Claim 9
Independent Claim 90 words
A method of treating a human infected with Human Immunodeficiency Virus comprising administering to said human a pharmaceutical composition that consists essentially of a virus neutralizing recombinant single chain antibody molecule selected from the group consisting of SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19 and SEQ ID NO:20 providing passive inmunity.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-11-23 2002-05-25 2002-11-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-11-23 2006-05-25 2006-11-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-11-23 2010-05-25 2010-11-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag